Cargando…

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease

The accumulation of extracellular amyloid-beta (Aβ), denoted as senile plaques, and intracellular neurofibrillary tangles (formed by hyperphosphorylated Tau protein) in the brain are two major neuropathological hallmarks of Alzheimer’s disease (AD). The current and most accepted hypothesis proposes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ordóñez-Gutiérrez, Lara, Wandosell, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261886/ https://www.ncbi.nlm.nih.gov/pubmed/32523525 http://dx.doi.org/10.3389/fnsyn.2020.00020

Ejemplares similares

Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
por: de la Cueva, Macarena, et al.
Publicado: (2022)

Author Correction: Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
por: de la Cueva, Macarena, et al.
Publicado: (2023)

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies
por: Medina, Miguel, et al.
Publicado: (2011)

Trehalose Reduces the Secreted Beta-Amyloid Levels in Primary Neurons Independently of Autophagy Induction
por: Benito-Cuesta, Irene, et al.
Publicado: (2021)

Diets with Higher ω-6/ω-3 Ratios Show Differences in Ceramides and Fatty Acid Levels Accompanied by Increased Amyloid-Beta in the Brains of Male APP/PS1 Transgenic Mice
por: Ordóñez-Gutiérrez, Lara, et al.
Publicado: (2021)

Neuronal and glial purinergic receptors functions in neuron development and brain disease
por: del Puerto, Ana, et al.
Publicado: (2013)

Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma
por: Sakae, Harumi, et al.
Publicado: (2023)

Ovarian Function Modulates the Effects of Long-Chain Polyunsaturated Fatty Acids on the Mouse Cerebral Cortex
por: Herrera, Jose L., et al.
Publicado: (2018)

Ovarian Hormone-Dependent Effects of Dietary Lipids on APP/PS1 Mouse Brain
por: Herrera, Jose Luis, et al.
Publicado: (2019)

Assessment of Autophagy in Neurons and Brain Tissue
por: Benito-Cuesta, Irene, et al.
Publicado: (2017)

Editorial: Neuroprotection in Synaptic Signalling During Neurological Disorders
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease
por: Wang, Lin, et al.
Publicado: (2022)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Editorial: Neuroprotection in Brain Hypoxia
por: Otero-Losada, Matilde, et al.
Publicado: (2019)

Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats
por: Liu, Xiangyan, et al.
Publicado: (2020)

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018)

Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
por: Traikapi, Artemis, et al.
Publicado: (2021)

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
por: Miao, Jifei, et al.
Publicado: (2023)

Preparation of Benzothiazolyl-Decorated Nanoliposomes
por: Mourtas, Spyridon, et al.
Publicado: (2019)

Folate-Targeted Nanoliposomal Chemophototherapy
por: Chitgupi, Upendra, et al.
Publicado: (2023)

Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease
por: Martínez-Pinilla, Eva, et al.
Publicado: (2016)

New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
por: Saito, Satoshi, et al.
Publicado: (2014)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
por: Uddin, Md. Sahab, et al.
Publicado: (2018)

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
por: Drew, Simon C.
Publicado: (2017)

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
por: Husain, Mohammed Amir, et al.
Publicado: (2021)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Editorial: Mechanisms, markers and therapeutics of synaptic pathology in Alzheimer's disease
por: Metaxas, Athanasios, et al.
Publicado: (2022)

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer’s Disease
por: Huang, Chun-Chao, et al.
Publicado: (2018)

Toward a Multimodal Computer-Aided Diagnostic Tool for Alzheimer’s Disease Conversion
por: Pena, Danilo, et al.
Publicado: (2022)

The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease
por: Cellai, Lucrezia, et al.
Publicado: (2018)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019)

Role of mTORC1 Controlling Proteostasis after Brain Ischemia
por: Perez-Alvarez, Maria J., et al.
Publicado: (2018)

Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia
por: Pérez-Álvarez, Maria Jose, et al.
Publicado: (2012)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

Commentary: The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer’s Disease
por: Squitti, Rosanna, et al.
Publicado: (2017)

The Emerging Roles and Therapeutic Potential of Soluble TREM2 in Alzheimer’s Disease
por: Zhong, Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rehhg4fig1d8hrd4idhpfldtg2